NF1 and cancer: The association between the MES gene expression signature, characterized by NF1 mutation, with reduced tumor purity, elevated invasion, enhanced migration capacity, and infiltration of immunosuppressive cells (macrophages, microglia, mesenchymal stem cells, or other cells) has been identified as a common theme across cancers (33, 34).